查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601217

豬疫苗市場：按適應症、技術、最終用戶分類 - 2025-2030 年全球預測

Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年豬疫苗市值為17.1億美元，預計2024年將達到18.2億美元，預計複合年成長率為6.72%，到2030年將達到27億美元。

豬隻疫苗市場包括保護豬隻免受傳染病並改善牛健康和生產力的疫苗的開發、生產和分銷。對此類疫苗的需求是為了防止養豬業因疾病爆發而遭受經濟損失。這些疫苗針對豬環狀病毒和豬繁殖與呼吸綜合症病毒（PRRSV）等病原體，透過注射或口服方式給不同年齡的豬注射。最終用途主要包括獸醫院、農場和研究機構。豬肉消費量的增加、動物健康意識的提高以及疫苗技術的進步對市場成長產生了重大影響。基因工程和生物技術領域的最新創新，例如重組疫苗和 DNA 疫苗，提供了利潤豐厚的機會。公司可以透過投資研發更有效、更容易管理的疫苗來利用這些優勢。此外，有機和永續農業實踐的成長趨勢正在增加對符合這些標準的疫苗的需求。然而，限制因素包括嚴格的法律規範減慢了核准流程、高昂的開發成本以及發展中地區的認知度和可用性有限。疫苗儲存和分配的物流也面臨挑戰，考慮到全球養豬氣候的多樣化，這可能特別複雜。此外，新病原體和不斷變化的菌株的出現強調了繼續研究和調整疫苗配方的必要性。創新的重點是提高疫苗功效和免疫力持續時間，以及開發單劑即可治療多種疾病的多功能疫苗。對用於疫苗傳輸的奈米技術和對病原體具有抵抗力的基因改造豬的研究也顯示出潛力。市場充滿活力，競爭激烈，並且穩步轉向生物解決方案。

主要市場統計
基準年[2023] 17.1億美元
預測年份 [2024] 18.2億美元
預測年份 [2030] 27億美元
複合年成長率（%） 6.72%

市場動態：快速發展的豬隻疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變豬隻疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球豬隻病患病率不斷上升
    • 對優質豬肉的需求不斷成長
    • 政府支持動物健康的舉措
  • 市場限制因素
    • 豬疫苗開發成本上升與儲存問題複雜
  • 市場機會
    • 豬疫苗的技術進步
    • 新型豬疫苗生產的良好投資環境
  • 市場挑戰
    • 豬隻疫苗的可用性和認知度有限，且有副作用

波特五力：駕馭豬疫苗市場的策略工具

波特的五力框架是了解豬隻疫苗市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解豬隻疫苗市場的外部影響

外部宏觀環境因素對豬隻疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解豬隻疫苗市場競爭狀況

對豬疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：豬隻疫苗市場供應商績效評估

FPNV定位矩陣是評估豬隻疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地豬病流行率不斷上升
      • 對優質豬肉的需求增加
      • 政府支持動物健康的舉措
    • 抑制因素
      • 豬疫苗開發高成本且儲存問題複雜
    • 機會
      • 豬疫苗的技術進步
      • 投資情勢有利於新型生產：豬隻疫苗
    • 任務
      • 豬隻疫苗的可得性和認知度有限，且有副作用
  • 市場區隔分析
    • 技術：基因工程和分子生物學技術的進步推動重組疫苗的創新
    • 最終用戶：生豬養殖場大規模疫苗接種計畫的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章豬疫苗市場依適應症分類

  • 關節炎
  • 腹瀉
  • 豬環狀病毒相關疾病
  • 豬繁殖與呼吸綜合症
  • 豬流感

第7章豬疫苗市場：依技術分類

  • 結合疫苗
  • DNA疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第8章豬疫苗市場：依最終用戶分類

  • 養豬場
  • 獸醫診所/醫院

第9章美洲豬疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太豬疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲豬疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zoetis 在英國推出 Circomax
    • 默克動物保健推出三合一豬疫苗
    • Elanco 是 Aptimmune 的 PRRS 去活化自體疫苗的美國獨家經銷商

公司名單

  • Bayer AG
  • Endovac Animal Health
  • Merck & Co., Inc.
  • FATRO SpA
  • Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
  • Yenher Agro-Products Sdn. Bhd.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago SA
  • Formosa Biomedical Inc.
  • Indian Immunologicals Ltd.
  • Kyoto Biken Laboratories, Inc.
  • PBS Animal Health
  • Bimeda Holdings PLC
  • HIPRA, SA
  • Zoetis Inc.
  • Aptimmune Biologics, Inc.
  • AVAC Vietnam Joint Stock Company
  • Eli Lilly and Company
  • Phibro Animal Health Corporation
  • Arko Laboratories
  • Genvax Technologies, Inc.
  • Nisseiken Co., Ltd.
  • Medgene Labs
  • Virbac SA
  • Ceva Sante Animale
  • KM Biologics Co., Ltd.
Product Code: MRR-742BD5183CF6

The Porcine Vaccines Market was valued at USD 1.71 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.72%, to USD 2.70 billion by 2030.

The porcine vaccines market encompasses the development, production, and distribution of vaccines used to protect pigs from infectious diseases, thereby enhancing herd health and productivity. The necessity for such vaccines is driven by the need to prevent economic losses in the swine industry due to disease outbreaks. These vaccines are applied via injection or oral administration to pigs of various age groups, targeting pathogens like Porcine Circovirus, Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and others. End-use scope primarily includes veterinary clinics, farms, and research institutions. Market growth is significantly influenced by rising pork consumption, increased awareness of animal health, and advancements in vaccine technology. Recent innovations in genetic and biotechnology such as recombinant vaccines and DNA vaccines offer lucrative opportunities. Companies can capitalize on these by investing in R&D for more effective and easy-to-administer vaccines. Additionally, the growing trend towards organic and sustainable farming practices highlights the demand for vaccines that comply with such standards. However, limitations include stringent regulatory frameworks that slow down the approval process, high development costs, and limited awareness and accessibility in developing regions. Challenges also arise from vaccine storage and distribution logistics, which can be particularly complex given the diverse climates in which swine are raised globally. Furthermore, the emergence of new pathogens and changing strains emphasize the need for continuous research and adaptation in vaccine formulation. Innovation can focus on enhancing the efficacy and duration of immunity of vaccines, as well as developing multifunctional vaccines that can combat multiple diseases in a single dose. Research into nanotechnology for vaccine delivery and pathogen-resistant genetically modified pigs also presents potential avenues. The market is dynamic with intense competition, witnessing a steady shift towards biologic solutions-a trend that market players must monitor to harness upcoming opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.71 billion
Estimated Year [2024] USD 1.82 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 6.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Porcine Vaccines Market

The Porcine Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in Prevalence of Swine Diseases Worldwide
    • Increasing Demand for High-Quality Pork Meat
    • Government Initiatives to Support Animal Health
  • Market Restraints
    • High Cost of Porcine Vaccine Development and Complex Storage Issues
  • Market Opportunities
    • Technological Advancements in Porcine Vaccine
    • Favorable Investment Landscape For Production of Novel Porcine Vaccines
  • Market Challenges
    • Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Porcine Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Porcine Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Porcine Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Porcine Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Porcine Vaccines Market

A detailed market share analysis in the Porcine Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Porcine Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Porcine Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Endovac Animal Health, Merck & Co., Inc., FATRO S.p.A., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Yenher Agro-Products Sdn. Bhd., Boehringer Ingelheim International GmbH, Biogenesis Bago S.A., Formosa Biomedical Inc., Indian Immunologicals Ltd., Kyoto Biken Laboratories, Inc., PBS Animal Health, Bimeda Holdings PLC, HIPRA, S.A., Zoetis Inc., Aptimmune Biologics, Inc., AVAC Vietnam Joint Stock Company, Eli Lilly and Company, Phibro Animal Health Corporation, Arko Laboratories, Genvax Technologies, Inc., Nisseiken Co., Ltd., Medgene Labs, Virbac SA, Ceva Sante Animale, and KM Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Arthritis, Diarrhea, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, and Swine Influenza.
  • Based on Technology, market is studied across Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines, Live attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
  • Based on End User, market is studied across Hog/Pig Production Farm and Veterinary Clinics/Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
      • 5.1.1.2. Increasing Demand for High-Quality Pork Meat
      • 5.1.1.3. Government Initiatives to Support Animal Health
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Porcine Vaccine
      • 5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
    • 5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Porcine Vaccines Market, by Indication

  • 6.1. Introduction
  • 6.2. Arthritis
  • 6.3. Diarrhea
  • 6.4. Porcine Circovirus Associated Disease
  • 6.5. Porcine Reproductive & Respiratory Syndrome
  • 6.6. Swine Influenza

7. Porcine Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Conjugate Vaccines
  • 7.3. DNA Vaccines
  • 7.4. Inactivated Vaccines
  • 7.5. Live attenuated Vaccines
  • 7.6. Recombinant Vaccines
  • 7.7. Toxoid Vaccines

8. Porcine Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Hog/Pig Production Farm
  • 8.3. Veterinary Clinics/Hospitals

9. Americas Porcine Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Porcine Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Porcine Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zoetis Launches Circomax In The UK
    • 12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
    • 12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune's PRRS Killed Autogenous Vaccine

Companies Mentioned

  • 1. Bayer AG
  • 2. Endovac Animal Health
  • 3. Merck & Co., Inc.
  • 4. FATRO S.p.A.
  • 5. Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
  • 6. Yenher Agro-Products Sdn. Bhd.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Biogenesis Bago S.A.
  • 9. Formosa Biomedical Inc.
  • 10. Indian Immunologicals Ltd.
  • 11. Kyoto Biken Laboratories, Inc.
  • 12. PBS Animal Health
  • 13. Bimeda Holdings PLC
  • 14. HIPRA, S.A.
  • 15. Zoetis Inc.
  • 16. Aptimmune Biologics, Inc.
  • 17. AVAC Vietnam Joint Stock Company
  • 18. Eli Lilly and Company
  • 19. Phibro Animal Health Corporation
  • 20. Arko Laboratories
  • 21. Genvax Technologies, Inc.
  • 22. Nisseiken Co., Ltd.
  • 23. Medgene Labs
  • 24. Virbac SA
  • 25. Ceva Sante Animale
  • 26. KM Biologics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PORCINE VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023